140,000 Women Die From Ovarian Cancer Each Year — New Diagnosing Method Saves Lives
Each year, 140,000 women around the world die, 14,000 alone are from the United States, due to ovarian cancer. Ovarian cancer is lethal because it is only detected once the cancer cells are already spreading across other tissues in the body. Majority of ovarian cancer deaths are caused by a serious histological tumor type, rarely being diagnosed before it has scattered throughout the body.
Researchers have developed a method of early ovarian cancer diagnosing with the aim of saving millions of lives in the future. The recurrent novel fusion transcript will play a great role in ovarian cancer’s pathogenesis of its substantial fraction, providing a molecular marker for its early detection. Molecular markers are very important since they will be used by scientists to provide better medical procedures to detect ovarian cancer still at curable stage and also provide new medical treatments once the cancer is already there.
Particular biomarkers that specifically have been found in most cancer forms are chromosomal rearrangements where 2 genes are fused producing a gene, recombinant one, that enhances cancer growth and spread throughout the body. Through deep sequencing of RNA molecules that carry ovarian cancer genetic information, scientists will be able to discover the rearrangement of at least 15% of tumors causing ovarian cancer.